MARKET NEWS

CureVac’s COVID-19 Vaccine Candidate Demonstrates Protection Against SARS-CoV-2 B.1.351 Variant in Preclinical Challenge Study
Dunad Therapeutics Emerges to Develop Next-Generation Small Molecule Therapeutics Based on First Tuneable Targeted Protein Degradation Technology
Visus Therapeutics Initiates Phase 2 Clinical Trial for Presbyopia Treatment
AstraZeneca’s & J&J’s COVID-19 Vaccines Manufacturing Face Viral Vector Shortages
Catalent Signs Drug Development Agreement With Cybin Inc
IONTAS Identifies Novel SARS-CoV-2 Neutralizing Antibodies

  FEATURED EDITORIAL

  COMPANY PROFILE

Pharmaceutical formulators continue to strive to create market leading products with maximum efficacy, quality, and performance. However, the inability to achieve a high level of API solubility and stability are common day-to-day challenges which limit product success. With the help from Croda’s superior quality and high purity line of specialty excipients, formulators are able to surpass these barriers, making Croda the supplier of choice in the global pharmaceutical market. With products being manufactured at multiple sites throughout the world, we are able to provide a consistent, local supply of a vast range of high purity surfactants, lipids, and other chemical specialties. Click here for more.

  EXCLUSIVE ONLINE CONTENT

PCI Broadens Clinical Trial Service Offerings at Berlin Facility

PCI Broadens Clinical Trial Service Offerings at Berlin Facility

PCI Pharma Services recently announce a new milestone in its global Clinical footprint with the expansion of cold chain clinical supply storage and distribution capabilities at its….

EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution & Storage of Doses Across European Union

EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution & Storage of Doses Across European Union

Pfizer Inc. and BioNTech SE recently announced the European Medicines Agency (EMA) approved storage of COMIRNATY at -25°C to -15°C for a total of 2 weeks….

Clinical Trial Data on the Use of Probiotics in Outpatients With COVID-19

Clinical Trial Data on the Use of Probiotics in Outpatients With COVID-19

Researchers at the Hospital General Manuel Gea González in Mexico City have reported results from a study designed to assess the impact of four specific strains of probiotics on the rate of remission from infection with SARS-CoV-2….

Agios Shareholders Approve Sale of Oncology Business to Servier

Agios Shareholders Approve Sale of Oncology Business to Servier

Agios Pharmaceuticals, Inc. recently announced its shareholders voted to approve the previously disclosed sale of its commercial, clinical, and research-stage oncology portfolio to….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

April 7 – Excipients
April 14 – Prefilled Syringes